1,700 HIV Treatment Sites Shut Down After Trump Aid Cuts, New Study Finds

What the Study Found

A new research analysis is putting hard numbers on something public health experts have been warning about for a while: cuts to U.S. foreign aid have real, measurable consequences. According to the study, roughly 1,700 HIV treatment sites around the world have shut down following reductions to Trump administration-era aid funding. These aren't just line items on a budget spreadsheet — they were clinics where people picked up antiretroviral medication, got tested, and received counseling to keep the virus in check.

Who's Getting Hit the Hardest

The research zeroes in on two groups facing outsized impact: children living with HIV and high-risk adult populations, which typically includes groups like sex workers, people who inject drugs, and men who have sex with men in regions where stigma already limits access to care. These are populations that depend heavily on consistent, judgment-free treatment access — and when a clinic disappears, there often isn't a backup option nearby. For kids especially, interrupted treatment can mean rising viral loads, more hospitalizations, and in the worst cases, preventable deaths.

Why Foreign Aid Cuts Hit HIV Care So Hard

Much of global HIV treatment infrastructure, particularly in sub-Saharan Africa and parts of Asia, has long relied on U.S.-funded programs like PEPFAR (the President's Emergency Plan for AIDS Relief). When funding gets slashed or paused, it's not a slow wind-down — clinics can close almost overnight, staff get laid off, and supply chains for medication break down fast. That's the mechanism researchers say led to this wave of site closures.

The Bigger Picture

Public health researchers have repeatedly flagged that global HIV progress over the past two decades — driving down transmission rates and death tolls significantly — was built on sustained funding commitments. This study suggests that even temporary disruptions can undo years of gains, particularly for vulnerable groups who have the least room for interrupted care. Experts are now watching whether funding gets restored, and how quickly, since the window to prevent long-term damage to treatment continuity is narrowing.

What to Watch Next

Expect follow-up reporting on which specific countries and regions were hit hardest, whether any of the 1,700 sites have reopened under alternative funding, and whether Congress or international health bodies step in to fill gaps. This is also likely to become a talking point in ongoing debates over U.S. foreign aid policy heading into future budget cycles.